"The INSPIRE trial is for men with localized prostate cancer who are suitable for treatment with Stereotactic Ablative Radiotherapy (SABR). This advanced form of radiotherapy represents an important step forward in prostate cancer treatment and has been shown to be an excellent treatment option in the highest quality trials."
"The main aim of INSPIRE is to reduce urinary side-effects, while also examining bowel and sexual side-effects. It will use advanced scanning and highly targeted radiotherapy to better protect nearby healthy tissue, while keeping treatment to just five sessions."
The INSPIRE trial focuses on men with localized prostate cancer suitable for Stereotactic Ablative Radiotherapy (SABR). It aims to reduce urinary side-effects and examine bowel and sexual side-effects. The trial will recruit over 130 patients across Ireland and is supported by Cancer Trials Ireland. SABR offers a shorter treatment course of five sessions over two weeks, providing comparable cancer control. The trial will utilize advanced scanning and a gel spacer to protect healthy tissue and minimize side-effects, with patient follow-up lasting five years.
#prostate-cancer #radiotherapy #clinical-trials #patient-quality-of-life #stereotactic-ablative-radiotherapy
Read at Irish Independent
Unable to calculate read time
Collection
[
|
...
]